NASDAQ:CASC Investor Notice : Lawsuit Filed in Effort to Halt the Takeover of Cascadian Therapeutics Inc (USA)
March 09, 2018 at 11:52 AM EST
San Diego, CA -- (SBWIRE) -- 03/09/2018 -- The Shareholders Foundation announces that an investor in NASDAQ:CASC shares filed a lawsuit against the acquisition of Cascadian Therapeutics Inc by Seattle Genetics, Inc for $10.00 per share.
